1. Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy

   • Kyriaki Ioannou
   • Pinelopi Samara
   • Ourania E. Tsitsilonis

   Review 26 February 2012 Pages: 599 - 614

   

2. Long-term proliferation of functional human NK cells, with conversion of CD56^dim NK cells to a CD56^bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12

   • Alexander C. Dowell
   • Kimberley A. Oldham
   • Peter F. Searle

   Original article 22 October 2011 Pages: 615 - 628

   

3. Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

   • Christina S. Chu
   • Jean Boyer
   • Carl H. June

   Original Article 22 October 2011 Pages: 629 - 641

   

4. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice

   • Melisa J. Hamilton
   • Judit P. Banáth
   • Kevin L. Bennewith

   Original article 22 October 2011 Pages: 643 - 654

   

5. Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma

   • Jun Zhou
   • Noah K. Yuen
   • F. Stephen Hodi

   Original article Open access 28 October 2011 Pages: 655 - 665

   

6. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells

   • Nanae Harashima
   • Tohko Inao
   • Mamoru Harada

   Original article 29 October 2011 Pages: 667 - 676

   

7. A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo

   • Jinpiao Lin
   • Rongfen Huo
   • Ningli Li

   Original Article 03 November 2011 Pages: 677 - 687

   

8. The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy

   • Laurence M. Wood
   • Zhen-Kun Pan
   • Yvonne Paterson

   Original article 06 November 2011 Pages: 689 - 700

   

9. Scutellaria extract and wogonin inhibit tumor-mediated induction of T_reg cells via inhibition of TGF-β1 activity

   • Sagar Dandawate
   • Linford Williams
   • Prahlad Parajuli

   Original article 06 November 2011 Pages: 701 - 711

   

10. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C

    • Adam E. Snook
    • Michael S. Magee
    • Scott A. Waldman

    Original article 06 November 2011 Pages: 713 - 723

    

11. Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy

    • Gustav J. Ullenhag
    • Arian M. Sadeghi
    • Thomas H. Tötterman

    Original article 23 December 2011 Pages: 725 - 732

    

12. Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab

    • Vafa Shahabi
    • Gena Whitney
    • Jeffrey R. Jackson

    Short communication 01 March 2012 Pages: 733 - 737

13. Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3–5, 2011

    • Natalia Aptsiauri
    • Teresa Cabrera
    • Federico Garrido

    Meeting report 21 February 2012 Pages: 739 - 745

14. Comment on “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy” by Gustav J. Ullenhag et al.

    • Inge Marie Svane

    Letter to the editors 20 March 2012 Pages: 747 - 747

15. Response to the letter to the editors from Inge Marie Svane on our manuscript “Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy”

    • Gunnar Wagenius
    • Gustav J. Ullenhag
    • Thomas H. Tötterman

    Letter to the editors 31 March 2012 Pages: 749 - 749